Briviact

Medicinal product

(Invented) name

Briviact

Active substance (s)

Brivaracetamas

Strength

50 mg

Pharmaceutical form

plėvele dengtos tabletės

Route (s) of administration

vartoti per burną

Legal status for supply

Receptinis

Narrow therapeutic index (NTI)

No

ATC code (s)

N03AX23, Brivaracetam

Marketing authorisation holder

UCB Pharma S.A., Belgija

Date of authorisation

2016-01-14

Date of renewal

Documents

Search in EMA Europe

Stage

Registruotas

Controlled?

No

Controlled substance type

Legal basis

8(3)

Procedure number

Marketing authorisation procedure

Centrinė registracija

Qualitative and quantitative composition

Film-coated tablet	1 vnt.
Brivaracetamas	50 mg

Packages

PAKID	NPAKID	NPAKID-7	Pack type	Pack size	Type of packaging	Proposed dispensing/classification	Marketing authorisation no.	Supply status	From	To	Package is in foreign language	From	To	Mock-up
65030	79526	1079526	lizdinė plokštelė	N14		Receptinis	EU/1/15/1073/009	Netiekiama	-	-	No	-	-
65031	79527	1079527	lizdinė plokštelė	N56		Receptinis	EU/1/15/1073/010	Netiekiama	-	-	No	-	-
65032	79528	1079528	dalomoji lizdinė plokštelė	N100x1		Receptinis	EU/1/15/1073/011	Netiekiama	-	-	No	-	-
65033	79529	1079529	lizdinė plokštelė	N168 (3x56) (sudėtinė)		Receptinis	EU/1/15/1073/012	Netiekiama	-	-	No	-	-
65982	80496	1080496	dalomoji lizdinė plokštelė	N14x1		Receptinis	EU/1/15/1073/025	Netiekiama	-	-	No	-	-

Stadijos

Data	Stadija
2016-01-14	Registruotas